Science Explorer Back to mapMap
Institution · Medicines360

Most cited papers from Medicines360

What are the most cited papers from Medicines360?

The most cited paper from Medicines360 is "Clinicians' Perspectives on Racism and Black Women's Maternal Health" (Brittany D. Chambers, Brianne Taylor, Tamara Nelson et al., 2022), with 75 citations. Next come "Levonorgestrel release rates over 5 years with the Liletta® 52-mg intrauterine system" (33) and "Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use" (28).

Showing 17 of 17 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Clinicians' Perspectives on Racism and Black Women's Maternal Health Brittany D. Chambers, Brianne Taylor, Tamara Nelson et al. · Women s Health Reports Open access May 2022 75
2 Levonorgestrel release rates over 5 years with the Liletta® 52-mg intrauterine system Mitchell David Creinin, Rolf Jansen, Robert M. Starr et al. · Contraception Open access 30 Apr 2016 33
3 Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use Mitchell David Creinin, Courtney A. Schreiber, David Keith Turok et al. · American Journal of Obstetrics and Gynecology Open access 13 May 2022 28
4 Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use Philip D. Darney, Gretchen S. Stuart, Michael A. Thomas et al. · Contraception Open access 14 Oct 2017 27
5 Assessing differences in contraceptive provision through telemedicine among reproductive health providers during the COVID-19 pandemic in the United States Alison B. Comfort, Lavanya Rao, Suzan Goodman et al. · Reproductive Health Open access 22 Apr 2022 24
6 Bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system Courtney A. Schreiber, Stephanie Beth Teal, Paul D. Blumenthal et al. · The European Journal of Contraception & Reproductive Health Care Open access 4 Mar 2018 23
7 Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding Beatrice A. Chen, David L. Eisenberg, Courtney A. Schreiber et al. · American Journal of Obstetrics and Gynecology 19 Dec 2019 20
8 Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system Carolyn L. Westhoff, Lisa M. Keder, Angelina K. Gangestad et al. · Contraception Open access 28 Nov 2019 17
9 Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years Melissa Lynn Gilliam, Jeffrey T. Jensen, David L. Eisenberg et al. · Contraception 28 Feb 2021 15
10 Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings Chun Chao, Jessica Chubak, Elisabeth F. Beaber et al. · Cancer Medicine Open access 15 Sep 2022 11
11 Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation Bruce Richard Carr, Michael A. Thomas, Angelina K. Gangestad et al. · Contraception Open access 8 Oct 2020 9
12 A Novel Approach for Treatment of Uterine Fibroids: Stereotactic Radiosurgery as a Proposed Treatment Modality CAMRAN R. NEZHAT, Nataliya Vang, Mailinh Vu et al. · Current Obstetrics and Gynecology Reports 23 Jan 2020 3
13 Return of fertility in nulliparous and parous women after levonorgestrel 52 mg intrauterine system discontinuation Bruce Richard Carr, Michael A. Thomas, Angelina K. Gangestad et al. · Fertility and Sterility Open access Sep 2018 3
14 Feasibility study of a single‐handed inserter for levonorgestrel 52 mg intrauterine device placement David L. Eisenberg, Courtney A. Schreiber, Paul D. Blumenthal et al. · Reproductive Female and Child Health Open access 2 Dec 2023 1
15 BLEEDING PATTERNS FROM MONTHS 60 TO 72 WITH USE OF A LEVONORGESTREL 52 MG INTRAUTERINE SYSTEM Jeffrey T. Jensen, Bruce Richard Carr, Thomas Kimble et al. · Fertility and Sterility Open access Sep 2020 1
16 Bleeding patterns do not differ between nulliparous and parous women using a levonorgestrel 52 mg intrauterine system Thomas Kimble, Bruce Richard Carr, David Keith Turok et al. · Fertility and Sterility Open access Sep 2018 1
17 Plasma levonorgestrel levels in non-obese and obese women using a levonorgestrel 52 mg intrauterine system for up to 7 years Mitchell David Creinin, Angelina K. Gangestad, Thomas Kimble et al. · Fertility and Sterility Open access Sep 2018 1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.